Molecular Contrast Optical Coherence Tomography and Its Applications in Medicine
- PMID: 35328454
- PMCID: PMC8949853
- DOI: 10.3390/ijms23063038
Molecular Contrast Optical Coherence Tomography and Its Applications in Medicine
Abstract
The growing need to understand the molecular mechanisms of diseases has prompted the revolution in molecular imaging techniques along with nanomedicine development. Conventional optical coherence tomography (OCT) is a low-cost in vivo imaging modality that provides unique high spatial and temporal resolution anatomic images but little molecular information. However, given the widespread adoption of OCT in research and clinical practice, its robust molecular imaging extensions are strongly desired to combine with anatomical images. A range of relevant approaches has been reported already. In this article, we review the recent advances of molecular contrast OCT imaging techniques, the corresponding contrast agents, especially the nanoparticle-based ones, and their applications. We also summarize the properties, design criteria, merit, and demerit of those contrast agents. In the end, the prospects and challenges for further research and development in this field are outlined.
Keywords: molecular contrast OCT; molecular contrast agent; molecular imaging; nanoparticles; optical coherence tomography.
Conflict of interest statement
The authors declare no conflict of interest.
Figures











Similar articles
-
Molecular contrast optical coherence tomography: a review.Photochem Photobiol. 2005 Mar-Apr;81(2):215-37. doi: 10.1562/2004-08-06-IR-266. Photochem Photobiol. 2005. PMID: 15588122 Free PMC article. Review.
-
Functional optical coherence tomography: principles and progress.Phys Med Biol. 2015 May 21;60(10):R211-37. doi: 10.1088/0031-9155/60/10/R211. Epub 2015 May 8. Phys Med Biol. 2015. PMID: 25951836 Free PMC article. Review.
-
Contrasting properties of gold nanoshells and titanium dioxide nanoparticles for optical coherence tomography imaging of skin: Monte Carlo simulations and in vivo study.J Biomed Opt. 2009 Mar-Apr;14(2):021017. doi: 10.1117/1.3122373. J Biomed Opt. 2009. PMID: 19405730
-
Advances in contrast enhancement for optical coherence tomography.Conf Proc IEEE Eng Med Biol Soc. 2006;2006:121-4. doi: 10.1109/IEMBS.2006.259366. Conf Proc IEEE Eng Med Biol Soc. 2006. PMID: 17946382 Review.
-
Investigation of Gd2O3: Er3+/Yb3+ Upconversion Nanoparticles (UCNPs) as a Multi-model Contrast Agent for Functional Optical Coherence Tomography (fOCT).J Fluoresc. 2021 Mar;31(2):541-550. doi: 10.1007/s10895-021-02681-9. Epub 2021 Jan 16. J Fluoresc. 2021. PMID: 33452637
Cited by
-
Advances in optical molecular imaging for neural visualization.Front Bioeng Biotechnol. 2023 Aug 21;11:1250594. doi: 10.3389/fbioe.2023.1250594. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37671191 Free PMC article. Review.
-
Optical coherence tomography for noninvasive monitoring of drug delivery.Adv Drug Deliv Rev. 2025 May;220:115571. doi: 10.1016/j.addr.2025.115571. Epub 2025 Mar 24. Adv Drug Deliv Rev. 2025. PMID: 40139506 Free PMC article. Review.
-
Optical theranostics in ischemic heart disease: from molecular insights to clinical translation.Theranostics. 2025 Jun 9;15(14):6789-6817. doi: 10.7150/thno.114307. eCollection 2025. Theranostics. 2025. PMID: 40585968 Free PMC article. Review.
-
Molecular Imaging in Nanomedical Research 2.0.Int J Mol Sci. 2022 Oct 27;23(21):13011. doi: 10.3390/ijms232113011. Int J Mol Sci. 2022. PMID: 36361796 Free PMC article.
-
Visualization of Atherosclerotic Plaques Paired with Joheksol 350 (Omnipaque).Biomedicines. 2025 Feb 7;13(2):399. doi: 10.3390/biomedicines13020399. Biomedicines. 2025. PMID: 40002812 Free PMC article.
References
-
- Yue L., Wang J., Dai Z., Hu Z., Chen X., Qi Y., Zheng X., Yu D. pH-Responsive, Self-Sacrificial Nanotheranostic Agent for Potential In Vivo and In Vitro Dual Modal MRI/CT Imaging, Real-Time, and In Situ Monitoring of Cancer Therapy. Bioconjugate Chem. 2017;28:400–409. doi: 10.1021/acs.bioconjchem.6b00562. - DOI - PubMed
-
- Beik J., Jafariyan M., Montazerabadi A., Ghadimi-Daresajini A., Tarighi P., Mahmoudabadi A., Ghaznavi H., Shakeri-Zadeh A. The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: Radiation dose reduction and image contrast enhancement. Artif. Cells Nanomed. Biotechnol. 2018;46:1993–2001. doi: 10.1080/21691401.2017.1408019. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources